1. Home
  2. TRDA vs TMCI Comparison

TRDA vs TMCI Comparison

Compare TRDA & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • TMCI
  • Stock Information
  • Founded
  • TRDA 2016
  • TMCI 2014
  • Country
  • TRDA United States
  • TMCI United States
  • Employees
  • TRDA N/A
  • TMCI N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • TRDA Health Care
  • TMCI Health Care
  • Exchange
  • TRDA Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • TRDA 548.2M
  • TMCI 464.4M
  • IPO Year
  • TRDA 2021
  • TMCI 2021
  • Fundamental
  • Price
  • TRDA $12.64
  • TMCI $8.71
  • Analyst Decision
  • TRDA Strong Buy
  • TMCI Hold
  • Analyst Count
  • TRDA 3
  • TMCI 8
  • Target Price
  • TRDA $25.67
  • TMCI $8.84
  • AVG Volume (30 Days)
  • TRDA 128.3K
  • TMCI 291.6K
  • Earning Date
  • TRDA 03-12-2025
  • TMCI 02-27-2025
  • Dividend Yield
  • TRDA N/A
  • TMCI N/A
  • EPS Growth
  • TRDA N/A
  • TMCI N/A
  • EPS
  • TRDA 1.55
  • TMCI N/A
  • Revenue
  • TRDA $215,232,000.00
  • TMCI $202,861,000.00
  • Revenue This Year
  • TRDA $47.45
  • TMCI $13.18
  • Revenue Next Year
  • TRDA N/A
  • TMCI $8.61
  • P/E Ratio
  • TRDA $8.18
  • TMCI N/A
  • Revenue Growth
  • TRDA 146.92
  • TMCI 16.14
  • 52 Week Low
  • TRDA $11.35
  • TMCI $3.92
  • 52 Week High
  • TRDA $21.79
  • TMCI $15.98
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 24.83
  • TMCI 63.78
  • Support Level
  • TRDA $12.02
  • TMCI $8.16
  • Resistance Level
  • TRDA $18.76
  • TMCI $8.64
  • Average True Range (ATR)
  • TRDA 0.92
  • TMCI 0.48
  • MACD
  • TRDA -0.51
  • TMCI 0.12
  • Stochastic Oscillator
  • TRDA 9.35
  • TMCI 93.09

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Share on Social Networks: